Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors

Trends in Neurosciences

Volumn 29, Issue 5, 2006, Pages 263-271

  Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; HEXANOIC ACID DERIVATIVE; NEUROPROTECTIN D1; UNCLASSIFIED DRUG;

APOPTOSIS; CELL SURVIVAL; GENE INDUCTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION; REVIEW;

ANIMALS; CELL DEATH; CELL SURVIVAL; DOCOSAHEXAENOIC ACIDS; HUMANS; NERVE DEGENERATION; OXIDATIVE STRESS; PHOTORECEPTORS; PIGMENT EPITHELIUM OF EYE; RETINAL DEGENERATION; SIGNAL TRANSDUCTION;

EID: 33646128251     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.03.005     Document Type: Review

References (82)

1. Chang G.Q., et al. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11 (1993) 595-605
2. Portera-Cailliau C., et al. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 974-978
3. Papermaster D.S. The birth and death of photoreceptors: the Friedenwald Lecture. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1300-1309
4. Bird A.C. The Bowman lecture. Towards an understanding of age-related macular disease. Eye 17 (2003) 457-466
5. Cideciyan A.V., et al. Mutations in ABCA4 result in accumulation of lipofucsin before slowing the retinoid cycle: a reappraisal of the human disease sequence. Hum. Mol. Genet. 13 (2004) 525-534
6. Dryja T.P., et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 343 (1990) 364-366
7. Liu Q., et al. The retinitis pigmentosa 1 protein is a photoreceptor microtubule-associated protein. J. Neurosci. 24 (2004) 6427-6436
8. Mendes H.F., et al. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11 (2005) 177-185
9. Chong N.H., et al. Decrease thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am. J. Pathol. 166 (2005) 241-251
10. Hageman G.S., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age- related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7227-7232
11. Gold, B. et al. (2006) Variation in factor B (BF) and complement 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. DOI: 10.1038/ng1750 (http://www.nature.com/ng/index.html)
12. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7053-7054
13. Sreekumar P.G., et al. Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochem. Biophys. Res. Commun. 334 (2005) 245-253
14. Feher, J. et al. (2005) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging DOI: 10.1016/j.neurobiolaging.2005.05.012 (http://www.sciencedirect.com/science/journal/01974580)
15. Bok D. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. Suppl. 17 (1993) 189-195
16. Fliesler S.J., and Bok D. Richard W. Young: and the band marched on. Trends Cell Biol. 9 (1999) 280-283
17. Marmorstein A.D. The polarity of the retinal pigment epithelium. Traffic 2 (2001) 867-872
18. Ershov A.V., et al. Selective transcription factor induction in retinal pigment epithelial cells during photoreceptor phagocytosis. J. Biol. Chem. 271 (1996) 28458-28462
19. Organisciak D.T., et al. Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2243-2257
20. Crabb J.W., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14682-14687
21. Aveldano M.I., and Bazan N.G. Molecular species of phosphatidylcholine, -ethanolamine, -serine, and -inositol in microsomal and photoreceptor membranes of bovine retina. J. Lipid Res. 24 (1983) 620-627
22. Aveldano M.I. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 27 (1988) 1229-1239
23. Bazan N.G., et al. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome. Biochem. Biophys. Res. Commun. 141 (1986) 600-604
24. Gong J., et al. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2596-2602
25. Hoffman D.R., and Birch D.G. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 36 (1995) 1009-1018
26. McColl A.J., and Converse C.A. Lipid studies in retinitis pigmentosa. Prog. Lipid Res. 34 (1995) 1-16
27. Schaefer E.J., et al. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J. Lipid Res. 36 (1995) 1427-1433
28. Niu S.L., et al. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J. Biol. Chem. 279 (2004) 31098-31104
29. Akbar M., et al. Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10858-10863
30. Anderson R.E., et al. Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol. Vis. 8 (2002) 351-358
31. Li F., et al. Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light. Exp. Eye Res. 73 (2001) 569-577
32. Rotstein N.P., et al. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J. Neurochem. 66 (1996) 1851-1859
33. Rotstein N.P., et al. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J. Neurochem. 69 (1997) 504-513
34. Calon F., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
35. Aveldano M.I., and Bazan N.G. Displacement into incubation medium by albumin of highly unsaturated retina free fatty acids arising from membrane lipids. FEBS Lett. 40 (1974) 53-56
36. Aveldano M.I., and Bazan N.G. Differential lipid deacylation during brain ischemia in a homeotherm and a poikilotherm. Content and composition of free fatty acids and triacylglycerols. Brain Res. 100 (1975) 99-110
37. Horrocks L.A., and Farooqui A.A. NMDA receptor-stimulated release of arachidonic acid: mechanisms for the Bazan effect. In: Municio A.M., and Miras-Portugal M.T. (Eds). Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease (1994), Plenum Press 113-128
38. Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J. Lipid Res. 44 (2003) 2221-2233
39. Sun G.Y., et al. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45 (2004) 205-213
40. Reddy T.S., and Bazan N.G. Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in retina. Curr. Eye Res. 3 (1984) 1225-1232
41. Bazan N.G., et al. Biochemical and nutritional aspects of the metabolism of polyunsaturated fatty acids and phospholipids in experimental models of retinal degeneration. In: LaVail M.M., et al. (Ed). Retinal Degeneration: Experimental and Clinical Studies (1985), Alan R. Liss, Inc. 159-187
42. Mukherjee P.K., et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8491-8496
43. Bazan N.G., et al. Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina. Biochem. Biophys. Res. Commun. 125 (1984) 741-747
44. Marcheselli V.L., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278 (2003) 43807-43817
45. Bossy-Wetzel E., et al. Molecular pathways to neurodegeneration. Nat. Med. 10 (2004) S2-S9
46. Mattson M.P., and Bazan N.G. Apoptosis and necrosis. In: Siegel G., et al. (Ed). Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 7th edn (2006), Elsevier 603-615
47. Osborne N.N., et al. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1390-1400
48. Liang Y.G., et al. Bcl-2, Bax, and c-Fos expression correlates to RPE cell apoptosis induced by UV-light and daunorubicin. Curr. Eye Res. 20 (2000) 25-34
49. Bryckaert M., et al. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene 18 (1999) 7584-7593
50. Bazan, N.G. et al. (2005) Pigment epithelium-derived growth factor (PEDF) selectively up-regulates NPD1 synthesis and release through the apical side of human RPE cells in primary cultures. Invest. Ophthalmol. Vis. Sci. 46, E-Abstract 167 (http://www.iovs.org/)
51. Lukiw W.J., et al. Neuroprotective and anti-inflammatory bioactive docosahexaenoic acid-derived mediators in Alzheimer's disease. J. Clin. Invest. 115 (2005) 2774-2783
52. Ershov A.V., and Bazan N.G. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors. J. Neurosci. Res. 58 (1999) 254-261
53. Hinton D.R., et al. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch. Ophthalmol. 116 (1998) 203-209
54. Sparrow J.R., and Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1356-1362
55. Barreiro, S.G. et al. (2005). Human retinal pigment epithelial cells protected by NPD1 after A2E-epoxide induction. Invest. Ophthalmol. Vis. Sci. 46, E-Abstract 250 (http://www.iovs.org/)
56. Scott B.L., and Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2903-2907
57. Zhang K., et al. A 5bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 27 (2001) 89-93
58. Belayev L., et al. DHA complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 36 (2005) 118-123
59. Berson E.L., et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch. Ophthalmol. 122 (2004) 1306-1314
60. Shen J., et al. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J. Cell. Physiol. 203 (2005) 457-464
61. Dentchev T., et al. Amyloid-β is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis. 14 (2003) 184-190
62. Luibl V., et al. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 116 (2006) 378-385
63. Scott B.L., et al. Developing rod photoreceptors from normal and mutant rd mouse retinas: altered fatty acid composition early in development of the mutant. J. Neurosci. Res. 20 (1988) 202-211
64. Rodriguez de Turco E.B., et al. Post-Golgi vesicles cotransport docosahexaenoyl-phospholipids and rhodopsin during frog photoreceptor membrane biogenesis. J. Biol. Chem. 272 (1997) 10491-10497
65. Deretic D. From the Golgi to the rod outer segment: formation, movement, docking and fusion of rhodopsin transport carriers. In: Williams D.S. (Ed). Photoreceptor Cell Biology and Inherited Retinal Degenerations (2004), World Scientific Publishing 29-65
66. de Caldironi M.I., and Bazan N.G. Acyl groups, molecular species, and labeling by 14C-glycerol and 3H-arachidonic acid of vertebrate retina glycerolipids. Adv. Exp. Med. Biol. 83 (1977) 397-404
67. Choe H.G., and Anderson R.E. Unique molecular species composition of glycerolipids of frog rod outer segments. Exp. Eye Res. 51 (1990) 159-165
68. Colangelo V., et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002) 462-473
69. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
70. Liao Y.F., et al. Tumor necrosis factor-α, interleukin-1β, and interferon-gamma stimulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J. Biol. Chem. 279 (2004) 49523-49532
71. Bhutto I.A., et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res. 82 (2005) 99-110
72. Finnemann S.C., et al. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3842-3847
73. Fliesler S.J., and Anderson R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22 (1983) 79-131
74. Neuringer M., et al. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 4021-4025
75. Marszalek J.R., and Lodish H.F. Docosahexaenoic acid, fatty acid interacting proteins, and neuronal function: breast milk and fish are good for you. Annu. Rev. Cell. Dev. Biol. 21 (2005) 633-657
76. SanGiovanni J.P., and Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24 (2005) 87-138
77. Neuringer M., et al. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest. 73 (1984) 272-276
78. Stinson A.M., et al. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J. Lipid Res. 32 (1991) 2009-2017
79. Uauy R.D., et al. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr. Res. 28 (1990) 485-492
80. Birch E.E., et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr. Res. 44 (1998) 201-209
81. Birch E.E., et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev. Med. Child Neurol. 42 (2000) 174-181
82. Bazan N.G. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15 (2005) 159-166